Navigation Links
Medial EarlySign and Centric Consulting Join Forces to Increase Hospital Adoption of Clinical AI Solutions
Date:7/18/2020

Medial EarlySign, a leader in AI-based clinical data solutions to aid in the early detection and prevention of high-burden diseases, and Centric Consulting, a business and technology consulting firm, today announced a partnership to enable US-based hospitals and healthcare organizations to utilize existing data in order to identify and prioritize patients for care.

Combining Centric’s management consulting services with EarlySign’s clinically validated AI-powered solutions, the two companies will work together to help healthcare organizations utilize data-backed insights in order to prioritize patient procedures, deliver focused interventions and re-engage populations.

EarlySign’s Infectious Disease bundle will be a primary focus, given the ongoing COVID-19 pandemic and the imminent arrival of flu season.

“Assisting hospitals in navigating clinical, operational and technology adoption challenges and providing outcome-focused care has always been of utmost importance at Centric. We see tremendous value in EarlySign’s platform which utilizes machine learning technology to help our clients facilitate proactive and strategic interventions for patients at high risk of a range of serious medical conditions,” said Marcie Stoshak-Chavez, MD, National Healthcare Practice Lead at Centric. “EarlySign’s validated framework of clinical solutions is perfectly aligned to address our clients’ immediate and long-term artificial intelligence strategies.”

The partnership follows the recent launch of EarlySign’s Back2Care suite of clinical data solutions and will provide hospitals with the tools to identify and prioritize high-risk patients and implement strategies for re-engagement of services.

The suite offers several solutions aimed at high-burden diseases, including the Infectious Disease bundle, Admissions bundle, Diabetes + Complications bundle, and an Early Detection bundle for diseases such as lung and colorectal cancer.

By using routine medical data collected over the course of care and drawing clinical insights into the best course of action for patients, healthcare organizations can optimize resources to provide more personalized and focused care.

“Working collaboratively with Centric to help drive transformational change will allow us to further our goal of advancing proactive healthcare and keeping populations healthy,” said Jeremy Orr MD, CEO of Medial EarlySign. “We are looking forward to further expanding our reach by engaging with Centric’s broad network to support hospitals in improving patient outcomes and navigating the transition back to necessary screening and care.”

ABOUT CENTRIC CONSULTING
Centric Consulting is a management consulting firm that guides you in the search for answers to complex digital, business and technology problems by asking tough questions, leading crucial conversations and blending our experts with yours. As you navigate what’s next, we can help you conquer change, optimize processes, elevate your technology, and compete in a digital world.

Headquartered in Ohio, with locations across the country and India, Centric has earned annual recognition by Forbes as one of America’s Best Management Consulting Firms since 2016. Visit http://www.centricconsulting.com to learn more.

Connect with Centric Consulting: LinkedIn | Twitter | Facebook | Instagram | YouTube

ABOUT MEDIAL EARLYSIGN
Medial EarlySign helps healthcare systems with early detection and prevention of high-burden diseases. Their suite of outcome-focused software solutions (AlgoMarkers™) find subtle, early signs of high-risk patient trajectories in existing lab results and ordinary EHR data already collected in the course of routine care. EarlySign’s AlgoMarkers and AI-based solutions can help clients identify and prioritize patients at high risk for a broad range of conditions. The algorithmic models developed using the company’s machine learning approach are supported by peer-reviewed research published by internationally recognized health organizations and hospitals. Founded in 2013, Medial EarlySign is headquartered in Tel Aviv, Israel with US headquarters in Colorado. For more information, please visit https://earlysign.com/.

Follow Medial EarlySign on LinkedIn: Medial EarlySign and Twitter: @MedialEarlySign

Read the full story at https://www.prweb.com/releases/medial_earlysign_and_centric_consulting_join_forces_to_increase_hospital_adoption_of_clinical_ai_solutions/prweb17263225.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. CSM to Host a Panel Session at ACRP Annual Meeting on Patient-Centric Medication with Direct-to-Patient Shipping
2. Brain State Technologies Announces Publication of Peer-Review Article Describing New Brain-Centric Model of Education
3. FedCentric Technologies, LLC Begins Collaboration With Frederick National Laboratory for Cancer Research
4. Patient-Centric Technology for Better Trial Outcomes, a New and Upcoming Clinical Trial Webinar Hosted by Xtalks
5. Lachman Introduces Lachman OnCall™, Offering Rapid-Response GMP Teleconsulting for Life Science Clients
6. Cold Chain Management Firm Modality Solutions Adds Carson Dickey to Its Consulting Engineer Team
7. Maryann Gallivan, President and CEO of Tunnell Consulting, Joins Forbes Business Development Council
8. Cold Chain Management Firm Modality Solutions Promotes Robert Battista to Senior Consulting Engineer
9. Tunnell Consulting’s Julia O’Neill Presents at Fall Technical Conference
10. Tunnell Consulting Joins Top Industry Experts at ISPE Conference
11. Trinity Sterile Selects The Copley Consulting Group to Implement Infor’s CloudSuite Industrial (Syteline)™ Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
(Date:7/1/2020)... , ... June 29, 2020 , ... ... to competitively procured purchasing contracts to its membership, recently named BioFit Engineered ... members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and ...
(Date:6/28/2020)... SAN JOSE, Calif. (PRWEB) , ... June 25, ... ... the globe, researchers are racing to develop a vaccine or drug treatment. In ... company Recursion has publicly released the world’s largest imaging dataset portraying ...
Breaking Biology Technology:
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first ... insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and ... be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com , ... biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology ... Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase 1 ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, ... the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga ... supply facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with ...
Breaking Biology News(10 mins):